These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 19672469)

  • 1. Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1.
    Carter JC; Church FC
    PPAR Res; 2009; 2009():345320. PubMed ID: 19672469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.
    Ma LJ; Mao SL; Taylor KL; Kanjanabuch T; Guan Y; Zhang Y; Brown NJ; Swift LL; McGuinness OP; Wasserman DH; Vaughan DE; Fogo AB
    Diabetes; 2004 Feb; 53(2):336-46. PubMed ID: 14747283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome Proliferator-Activated Receptor-γ Ligands Alter Breast Cancer Cell Motility through Modulation of the Plasminogen Activator System.
    Carter JC; Church FC
    J Oncol; 2011; 2011():594258. PubMed ID: 22131991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of plasminogen activator inhibitor-1 -675 4G/5G polymorphism on PAI-1 gene expression and adipocyte differentiation.
    Ozel Demiralp D; Aktas H; Akar N
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):438-46. PubMed ID: 18160587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts.
    Hao GH; Niu XL; Gao DF; Wei J; Wang NP
    Br J Pharmacol; 2008 Apr; 153(7):1409-19. PubMed ID: 18278065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.
    Vidal-Puig AJ; Considine RV; Jimenez-Liñan M; Werman A; Pories WJ; Caro JF; Flier JS
    J Clin Invest; 1997 May; 99(10):2416-22. PubMed ID: 9153284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of peroxisome proliferator-activated receptor-gamma decreases pancreatic cancer cell invasion through modulation of the plasminogen activator system.
    Sawai H; Liu J; Reber HA; Hines OJ; Eibl G
    Mol Cancer Res; 2006 Mar; 4(3):159-67. PubMed ID: 16547153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma.
    Revelo MP; Federspiel C; Helderman H; Fogo AB
    Nephrol Dial Transplant; 2005 Dec; 20(12):2812-9. PubMed ID: 16221712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1.
    Yu X; Li C; Li X; Cai L
    Toxicol Sci; 2007 Apr; 96(2):346-56. PubMed ID: 17264099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct attenuation of plasminogen activator inhibitor type-1 expression in human adipose tissue by thiazolidinediones.
    Zirlik A; Leugers A; Lohrmann J; Ernst S; Sobel BE; Bode C; Nordt TK
    Thromb Haemost; 2004 Apr; 91(4):674-82. PubMed ID: 15045127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced pan-peroxisome proliferator-activated receptor gene and protein expression in adipose tissue of diet-induced obese mice treated with telmisartan.
    Penna-de-Carvalho A; Graus-Nunes F; Rabelo-Andrade J; Mandarim-de-Lacerda CA; Souza-Mello V
    Exp Physiol; 2014 Dec; 99(12):1663-78. PubMed ID: 25326526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.
    Skurk T; Hauner H
    Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1357-64. PubMed ID: 15356668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A natural PPAR-gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, may act as an enhancer of PAI-1 in human proximal renal tubular cells under hypoxic and inflammatory conditions.
    Kimura H; Li X; Torii K; Okada T; Takahashi N; Fujii H; Ishihara S; Yoshida H
    Nephrol Dial Transplant; 2008 Aug; 23(8):2496-503. PubMed ID: 18367541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator inhibitor-1 modulates adipocyte differentiation.
    Liang X; Kanjanabuch T; Mao SL; Hao CM; Tang YW; Declerck PJ; Hasty AH; Wasserman DH; Fogo AB; Ma LJ
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E103-E113. PubMed ID: 16144810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines.
    Guo C; Ricchiuti V; Lian BQ; Yao TM; Coutinho P; Romero JR; Li J; Williams GH; Adler GK
    Circulation; 2008 Apr; 117(17):2253-61. PubMed ID: 18427128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor-α-mediated transcription of miR-301a and miR-454 and their host gene SKA2 regulates endothelin-1 and PAI-1 expression in sickle cell disease.
    Gonsalves CS; Li C; Malik P; Tahara SM; Kalra VK
    Biosci Rep; 2015 Oct; 35(6):. PubMed ID: 26460070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a peroxisome proliferator responsive element (PPRE)-like cis-element in mouse plasminogen activator inhibitor-1 gene promoter.
    Chen JG; Li X; Huang HY; Liu HL; Liu DG; Song TJ; Ma CG; Ma D; Song HY; Tang QQ
    Biochem Biophys Res Commun; 2006 Sep; 347(3):821-6. PubMed ID: 16843437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome Proliferator-Activated Receptor-γ: Master Regulator of Adipogenesis and Obesity.
    Shao X; Wang M; Wei X; Deng S; Fu N; Peng Q; Jiang Y; Ye L; Xie J; Lin Y
    Curr Stem Cell Res Ther; 2016; 11(3):282-9. PubMed ID: 26018229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.